Myocardial ischemia-reperfusion injury (MIRI) most frequently happens in acute myocardial infarction (AMI) when rapid reperfusion is utilized to save the ischemia myocardium. MIRI is the main contributing of poor healing in AMI and is related to high mortality and disability rates around the worldwide. Currently, there is no effective precautionary measure for MIRI. Ferroptosis is a novel regulated cell death characterized by iron overload and reactive oxygen species (ROS) accumulation, which lead to death membrane lipid peroxidation. An increasing amount of studies indicates that ferroptosis plays a vital role in the occurrence and progression of MIRI. Given the crucial role of ferroptosis in MIRI, it is critical to understand the cardiomyocyte iron metabolism and investigate the molecular mechanisms of ferroptosis. In this review, we systematically summarize the molecular and metabolic pathways of ferroptosis in context of MIRI, which could provide novel understandings for the pathophysiological machine and new ideas for treatment.
Highlights of the China cardiovascular health and disease report 2022. (2023). Chinese Journal of Cardiovascular28(04): 297–312.
2.
WangFYuYMubarikS, et al.Global burden of ischemic heart disease and attributable risk factors, 1990-2017: a secondary analysis based on the global burden of disease study 2017. Clin Epidemiol2021; 13: 859–870. DOI: 10.2147/clep.S317787.
3.
HausenloyDJChilianWCreaF, et al.The coronary circulation in acute myocardial ischaemia/reperfusion injury: a target for cardioprotection. Cardiovasc Res2019; 115(7): 1143–1155. DOI: 10.1093/cvr/cvy286.
4.
GrossGJAuchampachJA. Reperfusion injury: does it exist?J Mol Cell Cardiol2007; 42(1): 12–18. DOI: 10.1016/j.yjmcc.2006.09.009.
KalogerisTBainesCPKrenzM, et al.Ischemia/reperfusion. Compr Physiol2016; 7(1): 113–170. DOI: 10.1002/cphy.c160006.
7.
Sánchez-HernándezCDTorres-AlarcónLAGonzález-CortésA, et al.Ischemia/reperfusion injury: pathophysiology, current clinical management, and potential preventive approaches. Mediat Inflamm2020; 2020: 8405370. DOI: 10.1155/2020/8405370.
8.
HeuschG. Myocardial ischaemia-reperfusion injury and cardioprotection in perspective. Nat Rev Cardiol2020; 17(12): 773–789. DOI: 10.1038/s41569-020-0403-y.
9.
DavidsonSMAdameováABarileL, et al.Mitochondrial and mitochondrial-independent pathways of myocardial cell death during ischaemia and reperfusion injury. J Cell Mol Med2020; 24(7): 3795–3806. DOI: 10.1111/jcmm.15127.
10.
XiangQYiXZhuXH, et al.Regulated cell death in myocardial ischemia-reperfusion injury. Trends Endocrinol Metab2024; 35(3): 219–234. DOI: 10.1016/j.tem.2023.10.010.
11.
BaiJWangXDuS, et al.Study on the protective effects of danshen-honghua herb pair (DHHP) on myocardial ischaemia/reperfusion injury (MIRI) and potential mechanisms based on apoptosis and mitochondria. Pharm Biol2021; 59(1): 335–346. DOI: 10.1080/13880209.2021.1893346.
12.
RaatNJShivaSGladwinMT. Effects of nitrite on modulating ROS generation following ischemia and reperfusion. Adv Drug Deliv Rev2009; 61(4): 339–350. DOI: 10.1016/j.addr.2009.02.002.
13.
YanHFTuoQZYinQZ, et al.The pathological role of ferroptosis in ischemia/reperfusion-related injury. Zool Res2020; 41(3): 220–230.
14.
ZhangHYinYLiuY, et al.Necroptosis mediated by impaired autophagy flux contributes to adverse ventricular remodeling after myocardial infarction. Biochem Pharmacol2020; 175: 113915. DOI: 10.1016/j.bcp.2020.113915.
15.
SandangerØRanheimTVingeLE, et al.The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury. Cardiovasc Res2013; 99(1): 164–174. DOI: 10.1093/cvr/cvt091.
16.
KawaguchiMTakahashiMHataT, et al.Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury. Circulation2011; 123(6): 594–604. DOI: 10.1161/circulationaha.110.982777.
17.
MizushimaNKomatsuM. Autophagy: renovation of cells and tissues. Cell2011; 147(4): 728–741. DOI: 10.1016/j.cell.2011.10.026.
18.
ZhuHTannousPJohnstoneJL, et al.Cardiac autophagy is a maladaptive response to hemodynamic stress. J Clin Invest2007; 117(7): 1782–1793. DOI: 10.1172/jci27523.
19.
TannousPZhuHJohnstoneJL, et al.Autophagy is an adaptive response in desmin-related cardiomyopathy. Proc Natl Acad Sci U S A2008; 105(28): 9745–9750. DOI: 10.1073/pnas.0706802105.
20.
MatsuiYTakagiHQuX, et al.Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ Res2007; 100(6): 914–922. DOI: 10.1161/01.Res.0000261924.76669.36.
21.
SciarrettaSZhaiPShaoD, et al.Rheb is a critical regulator of autophagy during myocardial ischemia: pathophysiological implications in obesity and metabolic syndrome. Circulation2012; 125(9): 1134–1146. DOI: 10.1161/circulationaha.111.078212.
22.
LeiPBaiTSunY. Mechanisms of ferroptosis and relations with regulated cell death: a review. Front Physiol2019; 10: 139. DOI: 10.3389/fphys.2019.00139.
23.
TangLJLuoXJTuH, et al.Ferroptosis occurs in phase of reperfusion but not ischemia in rat heart following ischemia or ischemia/reperfusion. Naunyn-Schmiedeberg’s Arch Pharmacol2021; 394(2): 401–410. DOI: 10.1007/s00210-020-01932-z.
24.
LiWLiWLengY, et al.Ferroptosis is involved in diabetes myocardial ischemia/reperfusion injury through endoplasmic reticulum stress. DNA Cell Biol2020; 39(2): 210–225. DOI: 10.1089/dna.2019.5097.
25.
DixonSJLembergKMLamprechtMR, et al.Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell2012; 149(5): 1060–1072. DOI: 10.1016/j.cell.2012.03.042.
26.
ParaskevaidisIAIliodromitisEKVlahakosD, et al.Deferoxamine infusion during coronary artery bypass grafting ameliorates lipid peroxidation and protects the myocardium against reperfusion injury: immediate and long-term significance. Eur Heart J2005; 26(3): 263–270. DOI: 10.1093/eurheartj/ehi028.
27.
JomovaKMakovaMAlomarSY, et al.Essential metals in health and disease. Chem Biol Interact2022; 367(110173): 110173. DOI: 10.1016/j.cbi.2022.110173.
28.
SawickiKTDe JesusAArdehaliH. Iron metabolism in cardiovascular disease: physiology, mechanisms, and therapeutic targets. Circ Res2023; 132(3): 379–396. DOI: 10.1161/circresaha.122.321667.
29.
SharmaRJGrantDA. Fe3+(2)-transferrin and Fe3+(2)-asialotransferrin deliver iron to hepatocytes by an identical mechanism. Eur J Biochem1991; 195(1): 137–143. DOI: 10.1111/j.1432-1033.1991.tb15686.x.
30.
MasaldanSBushAIDevosD, et al.Striking while the iron is hot: iron metabolism and Ferroptosis in neurodegeneration. Free Radic Biol Med2018; 133: 221–233.
31.
ArosioPCarmonaFGozzelinoR, et al.The importance of eukaryotic ferritins in iron handling and cytoprotection. Biochem J2015; 472(1): 1–15. DOI: 10.1042/bj20150787.
32.
GanzT. Cellular iron: ferroportin is the only way out. Cell Metabol2005; 1(3): 155–157. DOI: 10.1016/j.cmet.2005.02.005.
33.
ConradMPronethB. Broken hearts: iron overload, ferroptosis and cardiomyopathy. Cell Res2019; 29(4): 263–264. DOI: 10.1038/s41422-019-0150-y.
34.
RouaultTA. The role of iron regulatory proteins in mammalian iron homeostasis and disease. Nat Chem Biol2006; 2(8): 406–414. DOI: 10.1038/nchembio807.
35.
BayevaMChangHCWuR, et al.When less is more: novel mechanisms of iron conservation. Trends Endocrinol Metab2013; 24(11): 569–577. DOI: 10.1016/j.tem.2013.07.003.
36.
SandlerHKrethJTimmersHT, et al.Not1 mediates recruitment of the deadenylase Caf1 to mRNAs targeted for degradation by tristetraprolin. Nucleic Acids Res2011; 39(10): 4373–4386. DOI: 10.1093/nar/gkr011.
WeisfeldtMLZweierJAmbrosioG, et al.Evidence that free radicals result in reperfusion injury in heart muscle. Basic Life Sci1988; 49: 911–919. DOI: 10.1007/978-1-4684-5568-7_149.
39.
LewerenzJHewettSJHuangY, et al.The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities. Antioxidants Redox Signal2013; 18(5): 522–555. DOI: 10.1089/ars.2011.4391.
40.
BannaiS. Exchange of cystine and glutamate across plasma membrane of human fibroblasts. J Biol Chem1986; 261(5): 2256–2263.
41.
ChenHCaoLHanK, et al.Patulin disrupts SLC7A11-cystine-cysteine-GSH antioxidant system and promotes renal cell ferroptosis both in vitro and in vivo. Food Chem Toxicol2022; 166: 113255. DOI: 10.1016/j.fct.2022.113255.
42.
BerdoukasVCoatesTDCabantchikZI. Iron and oxidative stress in cardiomyopathy in thalassemia. Free Radic Biol Med2015; 88(Pt A): 3–9. DOI: 10.1016/j.freeradbiomed.2015.07.019.
43.
JianHongLKunTaYWenSenL, et al.Xanthohumol protects the rat myocardium against ischemia/reperfusion injury-induced ferroptosis. Oxid Med Cell Longev2022; 2022.
44.
ShujunXBingxinWBiyingZ, et al.Naringenin alleviates myocardial ischemia/reperfusion injury by regulating the nuclear factor-erythroid factor 2-related factor 2 (Nrf2)/System xc-/glutathione peroxidase 4 (GPX4) axis to inhibit ferroptosis. Bioengineered2021; 12(2).
45.
TangLJZhouYJXiongXM, et al.Ubiquitin-specific protease 7 promotes ferroptosis via activation of the p53/TfR1 pathway in the rat hearts after ischemia/reperfusion. Free Radic Biol Med2021; 162: 339–352. DOI: 10.1016/j.freeradbiomed.2020.10.307.
46.
ShanXLvZYYinMJ, et al.The protective effect of cyanidin-3-glucoside on myocardial ischemia-reperfusion injury through ferroptosis. Oxid Med Cell Longev, 2021; 2021: 8880141. DOI: 10.1155/2021/8880141.
47.
TanyaRLuciaKMonikaB, et al.The molecular mechanisms of iron metabolism and its role in cardiac dysfunction and cardioprotection. Int J Mol Sci2020; 21(21).
48.
ChenXYuCKangR, et al.Iron metabolism in ferroptosis. Front Cell Dev Biol2020; 8: 590226. DOI: 10.3389/fcell.2020.590226.
49.
NaiALidonniciMRRausaM, et al.The second transferrin receptor regulates red blood cell production in mice. Blood2015; 125(7): 1170–1179. DOI: 10.1182/blood-2014-08-596254.
50.
KawabataHYangRHiramaT, et al.Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family. J Biol Chem1999; 274(30): 20826–20832. DOI: 10.1074/jbc.274.30.20826.
51.
HentzeMWMuckenthalerMUGalyB, et al.Two to tango: regulation of Mammalian iron metabolism. Cell2010; 142(1): 24–38. DOI: 10.1016/j.cell.2010.06.028.
52.
BoeroMPagliaroPTullioF, et al.A comparative study of myocardial molecular phenotypes of two tfr2β null mice: role in ischemia/reperfusion. Biofactors2015; 41(5): 360–371. DOI: 10.1002/biof.1237.
53.
Correction: cardiac ferroportin regulates cellular iron homeostasis and is important for cardiac function. Proc Natl Acad Sci USA2015; 112(14).
54.
ParkCHValoreEVWaringAJ, et al.Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem2001; 276(11): 7806–7810. DOI: 10.1074/jbc.M008922200.
55.
XuYAlfaro-MagallanesVMBabittJL. Physiological and pathophysiological mechanisms of hepcidin regulation: clinical implications for iron disorders. Br J Haematol2021; 193(5): 882–893. DOI: 10.1111/bjh.17252.
56.
MoiPChanKAsunisI, et al.Isolation of NF-E2-Related factor 2 (Nrf2), a NF-E2-Like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the β-globin locus control region. Proc Natl Acad Sci USA1994; 91(21).
57.
TianHXiongYZhangY, et al.Activation of NRF2/FPN1 pathway attenuates myocardial ischemia–reperfusion injury in diabetic rats by regulating iron homeostasis and ferroptosis. Cell Stress Chaperones2022; 27(2): 149–164.
58.
LiJZhongLWangF, et al.Dissecting the role of AMP-activated protein kinase in human diseases. Acta Pharm Sin B2017; 7(03): 249–259.
59.
GuCLiTJiangS, et al.AMP-activated protein kinase sparks the fire of cardioprotection against myocardial ischemia and cardiac ageing. Ageing Res Rev2018; 47.
60.
FuCYuSLiuZ, et al.PFKFB2 inhibits ferroptosis in myocardial ischemia/reperfusion injury through AMPK activation. J Cardiovasc Pharmacol2023; 82(2). DOI: 10.1097/fjc.0000000000001437.
61.
HaoyangLHuiXManyuD, et al.Britanin relieves ferroptosis-mediated myocardial ischaemia/reperfusion damage by upregulating GPX4 through activation of AMPK/GSK3β/Nrf2 signalling. Pharmaceut Biol2022; 60(1).
62.
MachadoSESpanglerDStacksDA, et al.Counteraction of myocardial ferritin heavy chain deficiency by heme oxygenase-1. Int J Mol Sci2022; 23(15). DOI: 10.3390/ijms23158300.
63.
HaiTWolfgangCDMarseeDK, et al.ATF3 and stress responses. Gene Expr1999; 7(4-6): 321–335.
64.
HaiqiongLHuaqiangMChaoboY, et al.A novel function of ATF3 in suppression of ferroptosis in mouse heart suffered ischemia/reperfusion. Free Radic Biol Med2022; 189.
65.
HouWXieYSongX, et al.Autophagy promotes ferroptosis by degradation of ferritin. Autophagy2016; 12(8): 1425–1428. DOI: 10.1080/15548627.2016.1187366.
66.
LiWLiWWangY, et al.Inhibition of DNMT-1 alleviates ferroptosis through NCOA4 mediated ferritinophagy during diabetes myocardial ischemia/reperfusion injury. Cell Death Dis2021; 7(1): 267. DOI: 10.1038/s41420-021-00656-0.
67.
BabaYHigaJKShimadaBK, et al.Protective effects of the mechanistic target of rapamycin against excess iron and ferroptosis in cardiomyocytes. Am J Physiol Heart Circ Physiol2018; 314(3): H659–h668. DOI: 10.1152/ajpheart.00452.2017.
68.
van MeerGVoelkerDRFeigensonGW. Membrane lipids: where they are and how they behave. Nat Rev Mol Cell Biol2008; 9(2): 112–124. DOI: 10.1038/nrm2330.
69.
PearsonANCarmichealJJiangL, et al.Contribution of lipid oxidation and ferroptosis to radiotherapy efficacy. Int J Mol Sci2021; 22(22). DOI: 10.3390/ijms222212603.
70.
StamenkovicAO'HaraKANelsonDC, et al.Oxidized phosphatidylcholines trigger ferroptosis in cardiomyocytes during ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol2021; 320(3): H1170–h1184. DOI: 10.1152/ajpheart.00237.2020.
71.
TangDChenXKangR, et al.Ferroptosis: molecular mechanisms and health implications. Cell Res2021; 31(2): 107–125. DOI: 10.1038/s41422-020-00441-1.
72.
YangWSKimKJGaschlerMM, et al.Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc Natl Acad Sci U S A2016; 113(34): E4966–4975. DOI: 10.1073/pnas.1603244113.
HeSLiRPengY, et al.ACSL4 contributes to ferroptosis-mediated rhabdomyolysis in exertional heat stroke. J Cachexia Sarcopenia Muscle2022; 13(3): 1717–1730. DOI: 10.1002/jcsm.12953.
75.
GrivennikovaVGVinogradovAD. Generation of superoxide by the mitochondrial Complex I. Biochim Biophys Acta2006; 1757(5-6): 553–561. DOI: 10.1016/j.bbabio.2006.03.013.
76.
KuhnHSaamJEibachS, et al.Structural biology of mammalian lipoxygenases: enzymatic consequences of targeted alterations of the protein structure. Biochem Biophys Res Commun2005; 338(1): 93–101. DOI: 10.1016/j.bbrc.2005.08.238.
77.
ZhaoWKZhouYXuTT, et al.Ferroptosis: opportunities and challenges in myocardial ischemia-reperfusion injury. Oxid Med Cell Longev2021; 2021: 9929687. DOI: 10.1155/2021/9929687.
ZouYLiHGrahamET, et al.Cytochrome P450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis. Nat Chem Biol2020; 16(3): 302–309. DOI: 10.1038/s41589-020-0472-6.
80.
MarcusCBettinaP. Broken hearts: iron overload, ferroptosis and cardiomyopathy. Cell Res2019; 29(4).
81.
SongLYangHWangHX, et al.Inhibition of 12/15 lipoxygenase by baicalein reduces myocardial ischemia/reperfusion injury via modulation of multiple signaling pathways. Apoptosis2014; 19(4): 567–580. DOI: 10.1007/s10495-013-0946-z.
82.
MaXHLiuJHLiuCY, et al.ALOX15-launched PUFA-phospholipids peroxidation increases the susceptibility of ferroptosis in ischemia-induced myocardial damage. Signal Transduct Targeted Ther2022; 7(1): 288. DOI: 10.1038/s41392-022-01090-z.
83.
CaiWLiuLShiX, et al.Alox15/15-HpETE aggravates myocardial ischemia-reperfusion injury by promoting cardiomyocyte ferroptosis. Circulation2023; 147(19): 1444–1460. DOI: 10.1161/circulationaha.122.060257.
84.
ZhangHLHuBXLiZL, et al.PKCβII phosphorylates ACSL4 to amplify lipid peroxidation to induce ferroptosis. Nat Cell Biol2022; 24(1): 88–98. DOI: 10.1038/s41556-021-00818-3.
85.
BannaiSIshiiT. A novel function of glutamine in cell culture: utilization of glutamine for the uptake of cystine in human fibroblasts. J Cell Physiol1988; 137(2): 360–366. DOI: 10.1002/jcp.1041370221.
86.
LiangCZhangXYangM, et al.Recent progress in ferroptosis inducers for cancer therapy. Adv Mater2019; 31(51): e1904197. DOI: 10.1002/adma.201904197.
87.
ViswanathanVSRyanMJDhruvHD, et al.Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature2017; 547(7664): 453–457. DOI: 10.1038/nature23007.
88.
ForcinaGCDixonSJ. GPX4 at the crossroads of lipid homeostasis and ferroptosis. Proteomics2019; 19(18): e1800311. DOI: 10.1002/pmic.201800311.
FanZWirthAKChenD, et al.Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis. Oncogenesis2017; 6(8): e371. DOI: 10.1038/oncsis.2017.65.
94.
ZhangYKoppulaPGanB. Regulation of H2A ubiquitination and SLC7A11 expression by BAP1 and PRC1. Cell Cycle2019; 18(8): 773–783. DOI: 10.1080/15384101.2019.1597506.
95.
MiyamotoHDIkedaMIdeT, et al.Iron overload via heme degradation in the endoplasmic reticulum triggers ferroptosis in myocardial ischemia-reperfusion injury. JACC Basic Transl Sci2022; 7(8): 800–819. DOI: 10.1016/j.jacbts.2022.03.012.
96.
ShimadaKHayanoMPaganoNC, et al.Cell-line selectivity improves the predictive power of pharmacogenomic analyses and helps identify NADPH as biomarker for ferroptosis sensitivity. Cell Chem Biol2016; 23(2): 225–235. DOI: 10.1016/j.chembiol.2015.11.016.
97.
ZhangYSwandaRVNieL, et al.mTORC1 couples cyst(e)ine availability with GPX4 protein synthesis and ferroptosis regulation. Nat Commun2021; 12(1): 1589. DOI: 10.1038/s41467-021-21841-w.
98.
DollSFreitasFPShahR, et al.FSP1 is a glutathione-independent ferroptosis suppressor. Nature2019; 575(7784): 693–698. DOI: 10.1038/s41586-019-1707-0.
99.
BersukerKHendricksJMLiZ, et al.The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature2019; 575(7784): 688–692. DOI: 10.1038/s41586-019-1705-2.
100.
SchieberMChandelNS. ROS function in redox signaling and oxidative stress. Curr Biol2014; 24(10): R453–462. DOI: 10.1016/j.cub.2014.03.034.
101.
D'AutréauxBToledanoMB. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol2007; 8(10): 813–824. DOI: 10.1038/nrm2256.
102.
HolmströmKMFinkelT. Cellular mechanisms and physiological consequences of redox-dependent signalling. Nat Rev Mol Cell Biol2014; 15(6): 411–421. DOI: 10.1038/nrm3801.
103.
WoodZAPooleLBKarplusPA. Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling. Science2003; 300(5619): 650–653. DOI: 10.1126/science.1080405.
104.
LennickeCCocheméHM. Redox metabolism: ROS as specific molecular regulators of cell signaling and function. Mol Cell2021; 81(18): 3691–3707. DOI: 10.1016/j.molcel.2021.08.018.
105.
PoursaitidisIWangXCrightonT, et al.Oncogene-selective sensitivity to synchronous cell death following modulation of the amino acid nutrient cystine. Cell Rep2017; 18(11): 2547–2556. DOI: 10.1016/j.celrep.2017.02.054.
106.
TrachoothamDLuWOgasawaraMA, et al.Redox regulation of cell survival. Antioxidants Redox Signal2008; 10(8): 1343–1374. DOI: 10.1089/ars.2007.1957.
107.
MishraPKAdameovaAHillJA, et al.Guidelines for evaluating myocardial cell death. Am J Physiol Heart Circ Physiol2019; 317(5): H891–h922. DOI: 10.1152/ajpheart.00259.2019.
108.
MurphyMP. How mitochondria produce reactive oxygen species. Biochem J2009; 417(1): 1–13. DOI: 10.1042/bj20081386.
109.
KaganVEMaoGQuF, et al.Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem Biol2017; 13(1): 81–90. DOI: 10.1038/nchembio.2238.
110.
Latunde-DadaGO. Ferroptosis: role of lipid peroxidation, iron and ferritinophagy. Biochim Biophys Acta Gen Subj2017; 1861(8): 1893–1900. DOI: 10.1016/j.bbagen.2017.05.019.
111.
TullioFAngottiCPerrelliMG, et al.Redox balance and cardioprotection. Basic Res Cardiol2013; 108(6): 392. DOI: 10.1007/s00395-013-0392-7.
112.
CohenMVYangXMDowneyJM. Acidosis, oxygen, and interference with mitochondrial permeability transition pore formation in the early minutes of reperfusion are critical to postconditioning's success. Basic Res Cardiol2008; 103(5): 464–471. DOI: 10.1007/s00395-008-0737-9.
113.
CohenMVYangXMDowneyJM. The pH hypothesis of postconditioning: staccato reperfusion reintroduces oxygen and perpetuates myocardial acidosis. Circulation2007; 115(14): 1895–1903. DOI: 10.1161/circulationaha.106.675710.
114.
LiuYYangXMIliodromitisEK, et al.Redox signaling at reperfusion is required for protection from ischemic preconditioning but not from a direct PKC activator. Basic Res Cardiol2008; 103(1): 54–59. DOI: 10.1007/s00395-007-0683-y.
115.
PennaCMancardiDRastaldoR, et al.Cardioprotection: a radical view Free radicals in pre and postconditioning. Biochim Biophys Acta2009; 1787(7): 781–793. DOI: 10.1016/j.bbabio.2009.02.008.
116.
RichardsonDRLaneDJBeckerEM, et al.Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol. Proc Natl Acad Sci U S A2010; 107(24): 10775–10782. DOI: 10.1073/pnas.0912925107.
117.
CorsiBCozziAArosioP, et al.Human mitochondrial ferritin expressed in HeLa cells incorporates iron and affects cellular iron metabolism. J Biol Chem2002; 277(25): 22430–22437. DOI: 10.1074/jbc.M105372200.
118.
DambrovaMZuurbierCJBorutaiteV, et al.Energy substrate metabolism and mitochondrial oxidative stress in cardiac ischemia/reperfusion injury. Free Radic Biol Med2021; 165: 24–37. DOI: 10.1016/j.freeradbiomed.2021.01.036.
119.
XueYFuWYuP, et al.Ginsenoside rc alleviates myocardial ischemia-reperfusion injury by reducing mitochondrial oxidative stress and apoptosis: role of SIRT1 activation. J Agric Food Chem2023; 71(3): 1547–1561. DOI: 10.1021/acs.jafc.2c06926.
120.
GaoFZhaoYZhangB, et al.Mitochondrial targeted astaxanthin liposomes for myocardial ischemia-reperfusion injury based on oxidative stress. J Biomater Appl2022; 37(2): 303–314. DOI: 10.1177/08853282221087102.
121.
KrainzTGaschlerMMLimC, et al.A mitochondrial-targeted nitroxide is a potent inhibitor of ferroptosis. ACS Cent Sci2016; 2(9): 653–659. DOI: 10.1021/acscentsci.6b00199.
122.
Rodríguez-GracianiKMChapa-DubocqXRAyala-ArroyoEJ, et al.Effects of ferroptosis on the metabolome in cardiac cells: the role of glutaminolysis. Antioxidants2022; 11(2). DOI: 10.3390/antiox11020278.
123.
KumfuSChattipakornSFucharoenS, et al.Mitochondrial calcium uniporter blocker prevents cardiac mitochondrial dysfunction induced by iron overload in thalassemic mice. Biometals2012; 25(6): 1167–1175. DOI: 10.1007/s10534-012-9579-x.
124.
BainesCPKaiserRAPurcellNH, et al.Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature2005; 434(7033): 658–662. DOI: 10.1038/nature03434.
125.
NakagawaTShimizuSWatanabeT, et al.Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature2005; 434(7033): 652–658. DOI: 10.1038/nature03317.
126.
HausenloyDJDuchenMRYellonDM. Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury. Cardiovasc Res2003; 60(3): 617–625. DOI: 10.1016/j.cardiores.2003.09.025.
127.
LemastersJJ. Evolution of voltage-dependent anion channel function: from molecular sieve to governator to actuator of ferroptosis. Front Oncol2017; 7: 303. DOI: 10.3389/fonc.2017.00303.
128.
FengYMadungweNBImam AliaganAD, et al.Liproxstatin-1 protects the mouse myocardium against ischemia/reperfusion injury by decreasing VDAC1 levels and restoring GPX4 levels. Biochem Biophys Res Commun2019; 520(3): 606–611. DOI: 10.1016/j.bbrc.2019.10.006.
129.
LinDCuiBRenJ, et al.Regulation of VDAC1 contributes to the cardioprotective effects of penehyclidine hydrochloride during myocardial ischemia/reperfusion. Exp Cell Res2018; 367(2): 257–263. DOI: 10.1016/j.yexcr.2018.04.004.
GleitzeSPaula-LimaANúñezMT, et al.The calcium-iron connection in ferroptosis-mediated neuronal death. Free Radic Biol Med2021; 175: 28–41. DOI: 10.1016/j.freeradbiomed.2021.08.231.
132.
MagdalenaSArturC-PYuriyS, et al.The impact of DIDS-induced inhibition of voltage-dependent anion channels (VDAC) on cellular response of lymphoblastoid cells to ionizing radiation. Medicinal chemistry (Shariqah (United Arab Emirates))2017; 13(5).
133.
NiYLiuJZengL, et al.Natural product manoalide promotes EGFR-TKI sensitivity of lung cancer cells by KRAS-ERK pathway and mitochondrial Ca(2+) overload-induced ferroptosis. Front Pharmacol2022; 13: 1109822. DOI: 10.3389/fphar.2022.1109822.
134.
ZhangKWuLZhangP, et al.miR-9 regulates ferroptosis by targeting glutamic-oxaloacetic transaminase GOT1 in melanoma. Mol Carcinog2018; 57(11): 1566–1576. DOI: 10.1002/mc.22878.
135.
KouYZhengWTZhangYR. Inhibition of miR-23 protects myocardial function from ischemia-reperfusion injury through restoration of glutamine metabolism. Eur Rev Med Pharmacol Sci2016; 20(20): 4286–4293.
136.
MaoCLiuXZhangY, et al.DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature2021; 593(7860): 586–590. DOI: 10.1038/s41586-021-03539-7.
137.
LöfflerMJöckelJSchusterG, et al.Dihydroorotat-ubiquinone oxidoreductase links mitochondria in the biosynthesis of pyrimidine nucleotides. Mol Cell Biochem1997; 174(1-2): 125–129.
BagherniyaMButlerAEBarretoGE, et al.The effect of fasting or calorie restriction on autophagy induction: a review of the literature. Ageing Res Rev2018; 47: 183–197. DOI: 10.1016/j.arr.2018.08.004.
140.
ZhouBLiuJKangR, et al.Ferroptosis is a type of autophagy-dependent cell death. Semin Cancer Biol2020; 66: 89–100. DOI: 10.1016/j.semcancer.2019.03.002.
141.
XieYLiJKangR, et al.Interplay between lipid metabolism and autophagy. Front Cell Dev Biol2020; 8: 431. DOI: 10.3389/fcell.2020.00431.
142.
LoosBGenadeSEllisB, et al.At the core of survival: autophagy delays the onset of both apoptotic and necrotic cell death in a model of ischemic cell injury. Exp Cell Res2011; 317(10): 1437–1453. DOI: 10.1016/j.yexcr.2011.03.011.
143.
SongXZhuSChenP, et al.AMPK-mediated BECN1 phosphorylation promotes ferroptosis by directly blocking system X(c)(-) activity. Curr Biol2018; 28(15): 2388–2399. DOI: 10.1016/j.cub.2018.05.094.
144.
LiuYWangYLiuJ, et al.Interplay between MTOR and GPX4 signaling modulates autophagy-dependent ferroptotic cancer cell death. Cancer Gene Ther2021; 28(1-2): 55–63. DOI: 10.1038/s41417-020-0182-y.
145.
ChenHYXiaoZZLingX, et al.ELAVL1 is transcriptionally activated by FOXC1 and promotes ferroptosis in myocardial ischemia/reperfusion injury by regulating autophagy. Mol Med2021; 27(1): 14. DOI: 10.1186/s10020-021-00271-w.
LeeYSLeeDHChoudryHA, et al.Ferroptosis-induced endoplasmic reticulum stress: cross-talk between ferroptosis and apoptosis. Mol Cancer Res2018; 16(7): 1073–1076. DOI: 10.1158/1541-7786.Mcr-18-0055.
148.
HongSHLeeDHLeeYS, et al.Molecular crosstalk between ferroptosis and apoptosis: emerging role of ER stress-induced p53-independent PUMA expression. Oncotarget2017; 8(70): 115164–115178.
149.
WangHAnPXieE, et al.Characterization of ferroptosis in murine models of hemochromatosis. Hepatology2017; 66(2): 449–465. DOI: 10.1002/hep.29117.
150.
CaoYLuoFPengJ, et al.KMT2B-dependent RFK transcription activates the TNF-α/NOX2 pathway and enhances ferroptosis caused by myocardial ischemia-reperfusion. J Mol Cell Cardiol2022; 173: 75–91. DOI: 10.1016/j.yjmcc.2022.09.003.
151.
MaXXuJGaoN, et al.Dexmedetomidine attenuates myocardial ischemia-reperfusion injury via inhibiting ferroptosis by the cAMP/PKA/CREB pathway. Mol Cell Probes2023; 68: 101899. DOI: 10.1016/j.mcp.2023.101899.
152.
Del ReDPAmgalanDLinkermannA, et al.Fundamental mechanisms of regulated cell death and implications for heart disease. Physiol Rev2019; 99(4): 1765–1817. DOI: 10.1152/physrev.00022.2018.
153.
RaniVDeepGSinghRK, et al.Oxidative stress and metabolic disorders: pathogenesis and therapeutic strategies. Life Sci2016; 148: 183–193. DOI: 10.1016/j.lfs.2016.02.002.
154.
MancardiDMezzanotteMArrigoE, et al.Iron overload, oxidative stress, and ferroptosis in the failing heart and liver. Antioxidants2021; 10(12): 1864. DOI: 10.3390/antiox10121864.
